U.S. Physical Therapy’s (USPH) “Market Outperform” Rating Reiterated at JMP Securities

JMP Securities reiterated their market outperform rating on shares of U.S. Physical Therapy (NYSE:USPH) in a research note published on Tuesday,Benzinga reports. JMP Securities currently has a $113.00 price target on the stock.

Other research analysts have also issued research reports about the stock. Barrington Research reduced their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. StockNews.com downgraded U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Thursday, April 17th. William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, JPMorgan Chase & Co. reduced their target price on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 19th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $109.00.

U.S. Physical Therapy Stock Up 2.2 %

U.S. Physical Therapy stock opened at $67.76 on Tuesday. U.S. Physical Therapy has a twelve month low of $62.77 and a twelve month high of $108.14. The business has a fifty day moving average of $75.69 and a two-hundred day moving average of $84.59. The firm has a market cap of $1.03 billion, a P/E ratio of 72.09, a P/E/G ratio of 3.54 and a beta of 1.38. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, analysts forecast that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 14th were given a $0.45 dividend. This represents a $1.80 annualized dividend and a dividend yield of 2.66%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is presently 97.83%.

Insider Buying and Selling

In other news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the transaction, the chief operating officer now directly owns 7,168 shares of the company’s stock, valued at approximately $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Several hedge funds and other institutional investors have recently bought and sold shares of USPH. CBIZ Investment Advisory Services LLC lifted its stake in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after acquiring an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in U.S. Physical Therapy during the fourth quarter valued at $39,000. Venturi Wealth Management LLC boosted its holdings in U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the last quarter. Fifth Third Bancorp grew its position in U.S. Physical Therapy by 34.6% during the 1st quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock worth $75,000 after purchasing an additional 265 shares during the period. Finally, Lazard Asset Management LLC purchased a new position in shares of U.S. Physical Therapy during the 4th quarter valued at about $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.